Nahed Balalaa
7 Papers
22 Citations
Nahed Balalaa is an academic researcher. The author has contributed to research in topics: Medicine & Breast cancer. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
•Journal Article
HIF-1α, VEGF and WT-1 are protagonists in bilateral primary angiosarcoma of breast: a case report and review of literature
TL;DR: HIF- 1α, WT-1 and VEGF are possible protagonists in the development of bilateral primary angiosarcoma of breast, the neoplastic process involves endothelial cell of blood vessels lineage rather than lymphatic lineage.
22
Breast Cancer in the United Arab Emirates
Humaid O. Al-Shamsi,Nadia A Abdelmegeed Abdelwahed,Aydah Al-Awadhi,Mohamed Albashir,Amin Abyad,Saeed Rafii,M.A. El Afrit,Bilal Al Lababidi,Ibrahim Abu-Gheida,Yoginee Pundlik Sonawane,Neil A. Nijhawan,Urfan Ul Haq,Norbert Dreier,Thanda Joshua,Faryal Iqbal,Tamer G. Yacoub,Faisal A. Nawaz,Dima Abdul Jabbar,Syed Hammad Tirmazy,Dalia El-Shourbagy,Dina Hamza,Mohamed Omara,Sawsan Abdul Salam Al Madhi,Hassan Ghazal,Humaa Darr,Muharrem Oner,Zoi Vlamaki,Abdul Rahman El Kinge,Dorai Ramanathan,Mohammed Judah,Taghreed Almahmeed,Mudhasir Ahmad,Sai Jonnada,Nahla Almansoori,Aly Razek,Annett Al-Hamadi,Nahed Balalaa,Faek R. Jamali,R A Singarachari,Abdel Karim S. Labban,Kaltar Das,Ernest J. T. Luiten,Tamer Abdelgawad,Falah Al-Khatib,Sadir Alrawi,Hassan Jaafar +45 more
TL;DR: Humaid O. Al-Shamsi, MD, Nadia Abdelwahed, MD; Aydah Al-Awadhi, MD and Mohamed Albashir, MD as discussed by the authors .
7
Pathologic Response of Associated Ductal Carcinoma In Situ to Neoadjuvant Systemic Therapy: A Systematic Review
TL;DR: In this article , a systematic review was conducted to determine the rate at which ductal carcinoma in situ (DCIS) was eradicated by chemotherapy and endocrine therapies administered prior to surgery, which determined to be 40.5% and 15% respectively.
Abstract P1-23-02: Incidence, clinicopathological features and treatment patterns of male breast cancer (MBC) in a high-volume cancer center in the United Arab Emirates (UAE)
TL;DR: The cohort indicates that the majority of the patients with MBC presented with higher grade, cT2 and above and node positive disease indicating the need for better awareness for early detection.
1
The Incidence of Thyroid Cancer in Bethesda III Thyroid Nodules: A Retrospective Analysis at a Single Endocrine Surgery Center
Iyad Hassan,Lina A. Hassan,Nahed Balalaa,Mohamad Askar,Hussa Alshehhi,Mohamad Almarzooqi +5 more
TL;DR: The incidence of malignancy in Bethesda III thyroid nodules is high, with a malignancy rate of 33.5% in the study population.
1